Late-stage peptide modification via aspartic acid as endogenous directing group

Mengjie Liao*, Bo Yao

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

Polypeptide drugs have become one of the most crucial tools in drug research and other related fields because of their high pharmacological activity, low dosage, low toxicity and side effects. However, the problems of poor metabolic stability, short half-value period and difficulty in penetration have greatly limit the development of new polypeptide drugs rendering the functional modification of peptides a crucial tool to polypeptide drugs. In this paper, we developed a new strategy for peptide functionalization through the usage of aspartic acid side chain as an endogenous directing group to realize polypeptide's selective bond arylation.

Original languageEnglish
Title of host publicationAdvances in Biomedical and Bioinformatics Engineering - Proceedings of the 3rd International Conference on Biomedicine and Bioinformatics Engineering, ICBBE 2023
EditorsYitao Yu, Binh P. Nguyen, Jun Sang
PublisherIOS Press BV
Pages62-67
Number of pages6
ISBN (Electronic)9781643684321
DOIs
Publication statusPublished - 23 Nov 2023
Event3rd International Conference on Biomedicine and Bioinformatics Engineering, ICBBE 2023 - Hybrid, Nanjing, China
Duration: 16 Jun 202318 Jun 2023

Publication series

NameStudies in Health Technology and Informatics
Volume308
ISSN (Print)0926-9630
ISSN (Electronic)1879-8365

Conference

Conference3rd International Conference on Biomedicine and Bioinformatics Engineering, ICBBE 2023
Country/TerritoryChina
CityHybrid, Nanjing
Period16/06/2318/06/23

Keywords

  • functionalization
  • peptide
  • Polypeptide drug
  • position selectivity

Fingerprint

Dive into the research topics of 'Late-stage peptide modification via aspartic acid as endogenous directing group'. Together they form a unique fingerprint.

Cite this